Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-03-12
2009-08-11
Li, Ruixiang (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S178100, C435S326000, C530S388240
Reexamination Certificate
active
07572447
ABSTRACT:
The invention provides methods and compositions for modulating vascularization and angiogenesis, including selective modulation of stages of multi-step vascularization and angiogenesis.
REFERENCES:
patent: 5468634 (1995-11-01), Liu
patent: 5547856 (1996-08-01), Godowski et al.
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5871697 (1999-02-01), Rothberg et al.
patent: 6099841 (2000-08-01), Hillan et al.
patent: 6365572 (2002-04-01), Stilz et al.
patent: 2002/0042372 (2002-04-01), Olsen et al.
patent: 93/23075 (1993-11-01), None
patent: 97/30065 (1997-08-01), None
patent: 98/31709 (1998-07-01), None
patent: 00/52051 (2000-09-01), None
patent: 00/55174 (2000-09-01), None
patent: WO 01/30969 (2001-05-01), None
patent: WO 01/32926 (2001-05-01), None
patent: 01/73025 (2001-10-01), None
Office Action mailed Nov. 24, 2004 in U.S. Appl. No. 09/703,350.
Adams, R.H., et al., “Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis”Genes and Development13(3):295-306 (1999).
Airenne, T., GenBank Accession No. U31201, record created Apr. 27, 1996.
Alberts et al.Molecular Biology of the Cell, 3RD edition, New York:Garland Publishing, Inc. pp. 465 (1994).
Amieva, M.R. et al., “Subcellular Localization of Moesin in Dynamic Filopodia, Retraction Fibers, and Other Structures Involved in Substrate Exploration, Attachment, and Cell-Cell Contacts”Exp. Cell Res. 219(1):180-196 (1995).
Antonarakis, S.E., GenBank Accession No. X91249, record created Aug. 21, 1996.
Arch, R.H. et al., “4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB”Mol Cell Biol18(1):558-565 (Jan. 1998).
Arnman, V. et al., “Interferon-γ modulates the fibrinolytic response in cultured human endothelial cells”Thrombosis Research77(5):431-440 (1995).
Arpin, M. et al., “Functional differences between L- and T-plastin isoforms”Journal of Cell Biology127(6 Pt 2):1995-2008 (1994).
Avanzi, G., et al., “GAS6 Inhibits Granulocyte Adhesion to Endothelial Cells”Blood91(7):2334-40 (1998).
Baum et al., “Identification of OX40 ligand and Preliminary Characterization of its Activities on OX40 Receptor”Circ. Shock44(1) :30-34. (1994).
Baum, P.R., et al., GenBank Accession No. S76792, record created Jun. 2, 2000.
Bement et al., “Cloning and mRNA Expression of Human Unconventional Myosin-IC. A Homologue of Amoeboid Myosins-I with a Single IQ Motif and an SH3 domain”J. Mol. Biol. 243(2) :356-363 (1994).
Bement, W.M., GenBank Accession No. U14391, record created Mar. 7, 1995.
Berquin, I.M. and B.F. Sloane, “Cathepsin B expression in human tumors”Adv. Exp. Med. Biol.389 :281-94 (1996).
Bird, I.N., et al., “Homophilic PECAM-1 (CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration”J. Cell Sci. 112(12) :1989-1997 (1999).
Bussolino et al., “Hepatocyte Growth Factor is a Potent Angiogenic Factor Which Stimulates Endothelial Cell Motility and Growth”Journal of Cell Biology119(3) :629-641 (Nov. 1992).
Cao, L. et al., “Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene”Gene139(2) :163-169. (1994).
Cao, L., et al., GenBank Accession No. L16510, record created Apr. 7, 1994.
Chan, S.J., et al., “Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs”Proc. Natl. Acad. Sci. USA. 83(20) :7721-7725. (1986).
Chan, S.J., et al., GenBank Accession No. M14221, record created Nov. 1, 1994.
Chang, A.C-M., et al., “A novel human cDNA highly homologous to the fish hormone stanniocalcin”Mol. Cell. Endocrinol. 112(2) :241-247. (1995).
Chang, A.C.-M., GenBank Accession No. U25997, record created Apr. 2, 1998.
Chen, H., et al., “Cloning of the cDNA for a Human Homologue of theDrosophilaWhite Gene and Mapping to Chromosome 21q22.3”Am. J. Hum. Genet. 59(1) :66-75. (1996).
Coluccio, L.M., “Differential calmodulin binding to three myosin-1 isoforms from liver”J. Cell. Sci. 107(Pt 8) :2279-2284 (1994).
Couffinhal et al., “Animal Model: Mouse Model of Angiogenesis”American Journal of Pathology152(6) :1667-1679 (1998).
Danilenko, D.M. et al., “Recombinant Rat Fibroblast Growth Factor-16: Structure and Biological Activity”Archives of Biochemistry&Biophysics361(1) :34-46 (1999).
Davis and Camarillo, “An α2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix”Experimental Cell Research224(1) :39-51 (Apr. 10, 1996).
Dick et al., “Cytoplasmic Dynein (ddlcl) Mutations Cause Morphogenetic Defects and Apoptotic Cell Death inDrosophila melanogaster” Molecular&Cellular Biology16(5) :1966-1977 (May 1996).
Dick, T., et al., GenBank Accession No. U32944, record created Jul. 23, 1996.
Dickinson, J.L. et al., “The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis”Cell Death Differ5(2) :163-71 (1998).
Dillman, “Monoclonal Antibodies for Treating Cancer”Annals of Internal Medicine111:592-603 (1989).
Docherty, A.J.P., GenBank Accession No. X05231, record created Mar. 30, 1995.
Dreesen, T.D. et al., “The Brown Protein ofDrosophila melanogasterIs Similar to the White Protein and to Components of Active Transport Complexes”Molecular&Cellular Biology8(12) :5206-15 (Dec. 1988).
Ferrara, N., “Role of Vascular Endothelial Growth Factor in Physiologic and Pathologic Angiogenesis: Therapeutic Implications”Seminars in Oncology29(6) :Suppl. 16:10-14 (2002).
Filvaroff et al., “Stanniocalcin 1 Alters Muscle and Bone Structure and Function in Transgenic Mice”Endocrinology143(9) :3681-3690 (2002).
Folkman et al., “Induction of angiogenesis during the transition from hyperplasia to neoplasia”Nature339(6219) :58-61 (1989).
Folkman, J., “Role of Angiogenesis in Tumor Growth and Metastasis”Seminars in Oncology29(6) :Suppl.16:15-18 (2002).
Freund, Y.R. and Blair, P.B., “Depression of Natural Killer Activity and Mitogen Responsiveness in Mice Treated with Pristane”J. Immunol. 129:2826-2830 (1982).
Fujiwara et al., “Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers”Int. J. Oncol. 16:799-804 (2000).
GenBank Accession No. NM—004431, record created Apr. 7, 2003.
GenBank Accession No. NM—005099, record created Apr. 6, 2003.
GenBank Accession No. P30530, record created Jun. 15, 2002.
GenBank Accession No. X03212, record created May 26, 1999.
Gerritsen et al., “In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set”Physiol. Genomics10(1) :13-20 (2002).
Gerritsen et al., “Stanniocalcin: No Longer Just a Fish Tale”Vitamins and Hormones70:105-135 (2005).
Glass et al., “Sequence and Expression of a Human Type II Mesothelial Keratin”Journal of Cell Biology101(6) :2366-2373 (Dec. 1985).
Godfrey, W. et al., “Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor”J. Experimental Medicine180(2) :757-762 (Aug. 1994).
Hager, G. et al., “A peptide derived from a neurite outgrowth-promoting domain on the γ l chain of laminin modulates the electrical properties of neocortical neurons”Neuroscience86(4) :1145-54 (1998).
Hammond, C. et al., “The Tetraspan Protein CD82 Is a Resident of MHC Class II Compartments Where It Associates with HLA-DR, -DM, and -DO Molec
Gerritsen Mary E.
Hongo Jo-Anne S.
Zlot Constance H.
Fang Carol A.
Genentech Inc.
Genentech, Inc.
Li Ruixiang
LandOfFree
Methods and compositions for selective modulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for selective modulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for selective modulation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087706